|
|
 |
|
Viewing report
|
|
|
|
Cold, Cough, And Sore Throat Remedies - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2010, Pages: 873
This report analyzes the worldwide markets for Cold, Cough, And Sore Throat Remedies in US$ Million.
The report provides separate comprehensive analytics for US, Canada, Japan, Europe, and Rest of World.
Annual forecasts are provided for each region for the period 2006 through 2015.
The report profiles 245 companies including many key and niche players worldwide such as:
- Aaron Industries Inc.
- AccuMed Inc.
- Bayer Corporation
- Biozone Laboratories Inc.
- First Boston Pharma LLC
- GlaxoSmithKline Pharmaceuticals
- Limited
- G.R.Lane Health Products
- Limited
- Johnson & Johnson
- Kalbe Farma Tbk
- Matrixx Initiatives Inc.
- Zicam LLC
- Nizhpharm OAO
- Novartis AG
- Perrigo Company
- Pharmstandard Group
- P. J. Noyes Company Inc.
- Procter & Gamble
- Ranbaxy Laboratories Limited
- Reckitt Benckiser Group plc
- Schering-Plough Corporation
- Taro Pharmaceuticals USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Thornton & Ross Ltd.
- Wyeth Consumer Healthcare.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Nicholas Hall's Global Cough, Cold & Allergy Review
Cough and Throat Remedies in the United States 2010
OTC Pediatrics in the United States 2010
Private Label OTC Healthcare in the United States 2010
Cold Flu and Allergy Remedies in the United States 2007
Allergy Drugs - Global Strategic Business Report
Nicholas Hall's OTC YearBook 2011 Report
Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
Sleeping Pills - Global Strategic Business Report
ADHD Therapeutics - Global Strategic Business Report
|
|
|
|
